Research and Markets: Global Stem Cell Research Products Report 2014 - Opportunities, Tools & Technologies Analysis
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/s3dhlh/stem_cell) has announced the addition of the "Global Stem Cell Research Products Report 2014 - Opportunities, Tools & Technologies Analysis" report to their offering.
“Global Stem Cell Research Products Report 2014 - Opportunities, Tools & Technologies Analysis”
There is conclusive evidence that entering the stem cell research products market is financially worthwhile. Full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell therapies market to be $3.31 billion, for a total of $6.53 billion. In addition, both markets are growing with double-digit growth. Producing stem cell research products thus represents a massive profit opportunity for research supply companies.
Pharmaceutical companies have intense interest in the ability to use stem cells to improve drug target validation and toxicology screening. Therefore, it is important for companies interested in stem cell therapy applications to understand underlying market forces, and in particular, to consider progressive areas of stem cell research as opportunistic areas for drug and therapy development. This report presents a range of topics of interest to these companies as well, including how advances in stem research can reveal potential new drug targets, improve methods of drug delivery, and provide personalized treatment strategies.
The key areas that account for the majority of applied stem cell research include:
- Regenerative Medicine - Reversal of injury or disease
- Drug Target Validation and Drug Delivery - Treatment of disease
- Toxicology Screening - Drug safety and efficacy assessment
- Understanding and Treatment of Birth Disorders - Natal repair
This 2014 report provides detailed information on both basic and applied stem cell research and research applications and includes an updated list of global stem cell research centers by region.
Furthermore, it is crucial for stem cell companies to understand the funding environment that supports stem cell research. Currently, the U.S. federal government is an important, although not dominant, source of funding for stem cell research. The reason is that U.S. states are spending almost as much as the federal government on stem cell research and are actually spending more than the federal government on human embryonic stem cell (hESC) research. Private sources also contribute a huge amount of funding, with analysis of recent large gifts summing to over $1.7 billion.
The stem cell types with the greatest year-to-year increases in publication rates over a trailing five-year period include:
- Mesenchymal stem cells
- Induced pluripotent stem cells
- Neural stem cells
Key Topics Covered:
II. Background: Types Of Stem Cells
III. Stem Cell Research Applications
IV. Key Market Competitors: Providers Of Diverse Stem Cell Product Lines
V. Product Areas
VI. Market Size
VII. Current Market Assessment
VIII. Market Trends: Detailed End-User Survey (Scientist Panel)
X. Strategies For Accessing The Marketplace
For more information visit http://www.researchandmarkets.com/research/s3dhlh/stem_cell